8Equity

The share capital amounts to CHF 342’623.70, made up of 34’262’370 shares with dividend entitlement and a par value of CHF 0.01. All shares are fully paid in and registered. On June 30, 2024, conditional share capital amounted to CHF 17’000 (December 31, 2023: CHF 17’000), consisting of 1'700’000 shares with a par value of CHF 0.01. 

Treasury shares

In the first half year 2024, the group acquired 150’000 treasury shares for CHF 15.7 million. The total number of treasury shares held by Sulzer Ltd as of June 30, 2024, was 378’924 shares (December 31, 2023: 451’074 shares). 

The treasury shares are mainly held for the purpose of issuing shares under the management share-based payment programs.

Dividends

On April 16, 2024, the Annual General Meeting approved an ordinary dividend of CHF 3.75 (2023: ordinary dividend of CHF 3.50) per share to be paid out of reserves. The dividend was paid to shareholders on April 22, 2024. The total amount of the dividend to shareholders of Sulzer Ltd was CHF 127.3 million (2023: CHF 118.9 million), thereof paid dividends of CHF 86.5 million (2023: CHF 80.9 million) and unpaid dividends of CHF 40.8 million (2023: CHF 38.1 million). The unpaid dividends are reflected in the balance sheet position “Other current and accrued liabilitiesˮ (see note 11).

Acquisition of non-controlling interests without change of control

Reference is made to note 3.

Contribution from medmix

The contribution relates to vested shares under Sulzer share plans for medmix employees.